The Cigna Group stock falls 1.03 percent after Q2 beat
Published on 09/25/2026 at 10:48 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
The Cigna Group stock stood at USD 265.50 on the NYSE on September 24, 2026, down 1.03 percent for the session and 15.84 percent below its 52-week high of USD 315.47. For Q2 2026, revenue reached USD 71.56 billion, while earnings per share came in at USD 7.78.
Q2 revenue beats expectations
As Zacks reported for the quarter ended June 2026, revenue rose 6.6 percent from USD 67.10 billion a year earlier to USD 71.56 billion. EPS increased from USD 7.20 to USD 7.78, exceeding the USD 7.58 consensus estimate by USD 0.20.
The revenue result also came in above the USD 71.43 billion consensus estimate. The comparison matters because Cigna's earnings growth was accompanied by a measurable sales beat rather than relying only on cost control.
Segments show different growth rates
According to Zacks, Evernorth Health Services generated USD 61.47 billion in Q2 2026 revenue, up 6.3 percent year over year, compared with a USD 61.57 billion consensus estimate. Cigna Healthcare revenue reached USD 11.84 billion, up 9.6 percent and above the USD 11.39 billion estimate.
The segment split gives the quarterly result a useful nuance. Evernorth remains the larger contributor by revenue, while the faster 9.6 percent growth at Cigna Healthcare provides a stronger expansion rate in the insurance business.
PBM transition sets next test
As Investing.com reported on September 9, 2026, Evercore ISI began coverage with an In Line rating and a USD 290 price target, citing transition risk in Cigna's pharmacy benefit management business. The same report said Guggenheim raised its target from USD 338 to USD 361 while retaining a Buy rating.
The next dated checkpoint is the company's investor day on September 30, 2026, according to the same Investing.com report. That event could clarify how management expects the PBM model to affect future profit growth.
Stock stays below yearly high
The Cigna Group market capitalization stood at USD 70,155,849,033 on September 24, 2026. The stock's 52-week range was USD 239.51 to USD 315.47, placing the latest price closer to the lower end than the yearly peak.
The reference price was USD 265.50 on the NYSE on September 24, 2026. The combination of a 1.03 percent daily decline, 6.6 percent quarterly revenue growth and a 15.84 percent gap to the yearly high leaves earnings execution and PBM transition details as the key factual markers for the stock.
The Cigna Group market data
- Company: The Cigna Group
- Ticker: CI
- Trading venue: NYSE
- Price as of September 24, 2026: USD 265.50
- Market capitalization: USD 70,155,849,033 as of September 24, 2026
- 52-week range: USD 239.51-315.47 as of September 24, 2026
- Sector / Industry: Healthcare / Medical Healthcare Plans
